- News & Features
On Dec. 14, Pfizer, which makes tofacitinib (Xeljanz), announced that the FDA had approved the drug for PsA.
Amjevita, a biosimilar to Humira (adalimumab), was approved by the FDA for treatment of a number of inflammatory diseases.
Dr. Kevin R. Stone with a crowd-sourcing solution for making doctors well-informed about the medical devices and treatments they use
Seth presents to an FDA advisory committee on the anti-nerve growth factor drug class, which could relieve pain.
Ms. Meniscus is asked about what to do in case there is a Methotrexate shortage.